• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童和青年成人剂型偏好咨询研究:为以患者为中心和基于患者信息的剂型开发铺平道路。

Dosage form preference consultation study in children and young adults: paving the way for patient-centred and patient-informed dosage form development.

作者信息

Alyami Hamad, Dahmash Eman, Alyami Fahad, Dahmash Dania, Huynh Chi, Terry David, Mohammed Afzal R

机构信息

Aston Pharmacy School, School of Life and Health Sciences, Aston University, Birmingham, UK.

Najran Maternity and Children Hospital, Najran, Saudi Arabia.

出版信息

Eur J Hosp Pharm. 2017 Nov;24(6):332-337. doi: 10.1136/ejhpharm-2016-001023. Epub 2016 Sep 2.

DOI:10.1136/ejhpharm-2016-001023
PMID:31156967
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6451603/
Abstract

OBJECTIVES

The current study aims to evaluate dosage form preferences in children and young adults together with identifying the key pragmatic dosage form characteristics that would enable appropriate formulation of orally disintegrating tablets (ODTs).

METHODS

International, multisite, cross-sectional questionnaire of children and young adults aged from 6 to 18 years. Eligibility was based on age, ability to communicate and previous experience in taking medications. The study was carried out at three locations: the UK, Saudi Arabia and Jordan. The questionnaire instrument was designed for participant self-completion under supervision of the study team.

RESULTS

104 questionnaires were completed by the study cohort (n=120, response rate 87%). Results showed that ODTs were the most preferred oral dosage forms (58%) followed by liquids (20%), tablets (12%) and capsules (11%). The preferred colours were pink or white while the preferred size was small (<8 mm) with a round shape. With regard to flavour, strawberry was the most preferred (30.8%), while orange was the least preferred (5.8%). The results also showed that the most important physical characteristics of ODTs were disintegration time followed by taste, size and flavour, respectively.

CONCLUSIONS

The results of our study support the WHO's claim for a shift of paradigm from liquid towards ODTs dosage forms for drug administration to young children older than 6 years. Data from this study will also equip formulators to prioritise development of key physical/performance attributes within the delivery system.

摘要

目的

本研究旨在评估儿童和青年对剂型的偏好,并确定有助于合理制备口腔崩解片(ODT)的关键实用剂型特征。

方法

针对6至18岁儿童和青年开展国际多中心横断面问卷调查。入选标准基于年龄、沟通能力和既往用药经验。研究在三个地点进行:英国、沙特阿拉伯和约旦。问卷由研究团队监督参与者自行填写。

结果

研究队列完成了104份问卷(n = 120,应答率87%)。结果显示,ODT是最受欢迎的口服剂型(58%),其次是液体制剂(20%)、普通片剂(12%)和胶囊剂(11%)。首选颜色为粉色或白色,首选尺寸为小尺寸(<8毫米)且为圆形。关于口味,草莓味最受欢迎(30.8%),而橙子味最不受欢迎(5.8%)。结果还表明,ODT最重要的物理特性分别是崩解时间,其次是味道、尺寸和口味。

结论

我们的研究结果支持世界卫生组织的主张,即对于6岁以上儿童给药,剂型模式应从液体制剂向ODT转变。本研究数据还将帮助配方设计师确定给药系统中关键物理/性能属性的开发优先级。

相似文献

1
Dosage form preference consultation study in children and young adults: paving the way for patient-centred and patient-informed dosage form development.儿童和青年成人剂型偏好咨询研究:为以患者为中心和基于患者信息的剂型开发铺平道路。
Eur J Hosp Pharm. 2017 Nov;24(6):332-337. doi: 10.1136/ejhpharm-2016-001023. Epub 2016 Sep 2.
2
Current opinions and recommendations of paediatric healthcare professionals - The importance of tablets: Emerging orally disintegrating versus traditional tablets.儿科保健专业人员的当前观点和建议 - 片剂的重要性:新兴的口腔崩解片与传统片剂。
PLoS One. 2018 Feb 28;13(2):e0193292. doi: 10.1371/journal.pone.0193292. eCollection 2018.
3
Orally disintegrating tablets and orally disintegrating mini tablets - novel dosage forms for pediatric use.口崩片和口崩迷你片-儿科新剂型。
Pharm Dev Technol. 2019 Sep;24(7):902-914. doi: 10.1080/10837450.2019.1615090.
4
A multicenter, open-label, sequential study comparing preferences for carbidopa-levodopa orally disintegrating tablets and conventional tablets in subjects with Parkinson's disease.一项多中心、开放标签、序贯研究,比较帕金森病患者对卡比多巴-左旋多巴口腔崩解片和常规片剂的偏好。
Clin Ther. 2005 Jan;27(1):58-63. doi: 10.1016/j.clinthera.2005.01.004.
5
Ease of Taking and Palatability of Fixed-Dose Orally Disintegrating Mitiglinide/Voglibose Tablets.固定剂量口服崩解米格列奈/伏格列波糖片的服用便利性和口感
Chem Pharm Bull (Tokyo). 2019;67(6):540-545. doi: 10.1248/cpb.c18-00902.
6
Evaluation of palatability of 10 commercial amlodipine orally disintegrating tablets by gustatory sensation testing, OD-mate as a new disintegration apparatus and the artificial taste sensor.采用味觉测试、OD-mate 新型崩解装置和人工味觉传感器评价 10 种市售氨氯地平口腔崩解片的口感。
J Pharm Pharmacol. 2013 Sep;65(9):1312-20. doi: 10.1111/jphp.12101. Epub 2013 Jul 10.
7
Recent Formulation Advances and Therapeutic Usefulness of Orally Disintegrating Tablets (ODTs).口腔崩解片(ODTs)的最新剂型进展及治疗应用价值
Pharmacy (Basel). 2020 Oct 10;8(4):186. doi: 10.3390/pharmacy8040186.
8
Orodispersible tablets for pediatric drug delivery: current challenges and recent advances.用于儿科药物传递的口崩片:当前的挑战和最新进展。
Expert Opin Drug Deliv. 2021 Dec;18(12):1873-1890. doi: 10.1080/17425247.2021.2011856. Epub 2021 Dec 3.
9
Development and optimization of taste-masked orally disintegrating tablets (ODTs) of clindamycin hydrochloride.盐酸克林霉素口腔崩解片的掩味技术开发与优化
Drug Dev Ind Pharm. 2015;41(7):1156-64. doi: 10.3109/03639045.2014.935392. Epub 2014 Jul 7.
10
A survey of caregivers of Nigerian children less than 6 years of age to determine the experience and perception of acceptability of oral solid dosage forms.对尼日利亚 6 岁以下儿童的照顾者进行调查,以确定他们对口服固体制剂的可接受性的经验和看法。
Int J Pharm. 2018 Feb 5;536(2):582-589. doi: 10.1016/j.ijpharm.2017.10.047. Epub 2017 Nov 1.

引用本文的文献

1
Nanotechnological innovations in paediatric tuberculosis management: current trends and future prospects.儿科结核病管理中的纳米技术创新:当前趋势与未来前景
Front Drug Deliv. 2024 Jan 8;3:1295815. doi: 10.3389/fddev.2023.1295815. eCollection 2023.
2
Dual-Responsive Ion-Exchange Resin Encapsulated Atomoxetine Hydrochloride for Taste-Masking and Biphasic Release.用于掩味和双相释放的双响应离子交换树脂包封盐酸托莫西汀
AAPS PharmSciTech. 2025 Apr 29;26(5):118. doi: 10.1208/s12249-025-03111-w.
3
Net Promoter Score Model for Evaluating Paediatric Medicine Acceptability: Validation and Feasibility Study.用于评估儿科药物可接受性的净促进者得分模型:验证与可行性研究
Pharmaceutics. 2024 Nov 25;16(12):1513. doi: 10.3390/pharmaceutics16121513.
4
The impact of patients' preference for pharmaceutical dosage forms on medication discontinuation among patients attending Red Cross pharmacies in Northwest Ethiopia.在埃塞俄比亚西北部红十字会药房就诊的患者中,患者对药物剂型的偏好对停药的影响。
Sci Rep. 2024 Nov 20;14(1):28751. doi: 10.1038/s41598-024-76113-6.
5
Patients' Preference for Pharmaceutical Dosage Forms: Does It Affect Medication Adherence? A Cross-Sectional Study in Community Pharmacies.患者对药物剂型的偏好:这会影响药物依从性吗?一项在社区药房开展的横断面研究。
Patient Prefer Adherence. 2024 Mar 26;18:753-766. doi: 10.2147/PPA.S456117. eCollection 2024.
6
Colour of Medicines and Children's Acceptability? A Systematic Literature Review of Children's Perceptions about Colours of Oral Dosage Forms.药品颜色与儿童接受度?关于儿童对口服剂型颜色认知的系统文献综述
Pharmaceutics. 2023 Jul 20;15(7):1992. doi: 10.3390/pharmaceutics15071992.
7
Potency of Xanthone Derivatives from L. for COVID-19 Treatment through Angiotensin-Converting Enzyme 2 and Main Protease Blockade: A Computational Study.黄烷酮衍生物通过抑制血管紧张素转换酶 2 和主要蛋白酶治疗 COVID-19 的效力:一项计算研究。
Molecules. 2023 Jul 4;28(13):5187. doi: 10.3390/molecules28135187.
8
Taste Masking of Promethazine Hydrochloride Using l-Arginine Polyamide-Based Nanocapsules.使用 l-精氨酸聚酰胺基纳米胶囊掩蔽盐酸异丙嗪的味道。
Molecules. 2023 Jan 11;28(2):748. doi: 10.3390/molecules28020748.
9
Data-enriched edible pharmaceuticals (DEEPs): Patients' preferences, perceptions, and acceptability of new dosage forms and their digital aspects - An interview study.数据丰富的可食用药物(DEEPs):患者对新剂型及其数字方面的偏好、认知和可接受性——一项访谈研究。
Explor Res Clin Soc Pharm. 2022 Apr 22;6:100141. doi: 10.1016/j.rcsop.2022.100141. eCollection 2022 Jun.
10
Preference, Perception, and Acceptability of Fluid Gels as a Potential Age-Appropriate Dosage Form for Elderly Patients with Dysphagia.作为吞咽困难老年患者潜在的适宜剂型,液体凝胶的偏好、认知及可接受性
Gels. 2022 Apr 1;8(4):218. doi: 10.3390/gels8040218.

本文引用的文献

1
Developing drugs for children and the adjustment of medication-is it a new challenge or an adaptation of past ideas?为儿童开发药物和调整药物剂量——这是新的挑战还是对过去观念的调整?
J Pers Med. 2011 Dec 6;1(1):5-16. doi: 10.3390/jpm1010005.
2
General public knowledge, preferred dosage forms, and beliefs toward medicines in western Saudi Arabia.沙特阿拉伯西部公众的常识、首选剂型及对药物的看法。
Saudi Med J. 2014 Jun;35(6):578-84.
3
WHO guideline development of paediatric medicines: points to consider in pharmaceutical development.世界卫生组织儿科药物指南制定:药物研发中需考虑的要点。
Int J Pharm. 2012 Oct 5;435(2):134-5. doi: 10.1016/j.ijpharm.2012.05.054.
4
Acceptance of uncoated mini-tablets in young children: results from a prospective exploratory cross-over study.小儿口服非包衣迷你片剂的顺应性:一项前瞻性探索性交叉研究的结果。
Arch Dis Child. 2012 Mar;97(3):283-6. doi: 10.1136/archdischild-2011-300958. Epub 2012 Jan 17.
5
European Paediatric Formulation Initiative's (EuPFI) 2nd conference commentary--Formulating better medicines for children.欧洲儿科制剂倡议组织(EuPFI)第二届会议评论——为儿童研发更优质的药物
Int J Pharm. 2011 Oct 31;419(1-2):235-9. doi: 10.1016/j.ijpharm.2011.06.040. Epub 2011 Jun 29.
6
The status of paediatric medicines initiatives around the world--What has happened and what has not?全球儿科药物倡议的现状——已经发生了什么,还有什么没有发生?
Eur J Clin Pharmacol. 2012 Jan;68(1):1-10. doi: 10.1007/s00228-011-1089-1. Epub 2011 Jul 6.
7
Early clinical development of artemether-lumefantrine dispersible tablet: palatability of three flavours and bioavailability in healthy subjects.青蒿琥酯-氨酚喹啉分散片的早期临床开发:三种口味的口感和健康受试者的生物利用度。
Malar J. 2010 Sep 3;9:253. doi: 10.1186/1475-2875-9-253.
8
European perspectives on pediatric formulations.欧洲对儿科制剂的看法。
Clin Ther. 2008 Nov;30(11):2146-54. doi: 10.1016/j.clinthera.2008.11.016.
9
Paediatric clinical pharmacology: at the beginning of a new era.儿科临床药理学:新时代的开端。
Eur J Clin Pharmacol. 2008 Feb;64(2):201-5. doi: 10.1007/s00228-007-0390-5. Epub 2007 Oct 31.
10
Sucrose-induced analgesia is related to sweet preferences in children but not adults.蔗糖诱导的镇痛作用与儿童而非成人的甜味偏好有关。
Pain. 2005 Dec 15;119(1-3):210-218. doi: 10.1016/j.pain.2005.09.029. Epub 2005 Nov 18.